Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2013

Shareholders' Equity

Share-Based Activity

	2013		2012		2011
Share-based compensation expense	$	8,321	$	6,692	$	6,178
Fair value of shares vested		11,742		6,425		7,356
Cash received from option exercises		33,349		18,214		6,872
Tax benefit from option exercises		7,247		1,784		977

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at January 1, 2011		664,909	$	22.16
	Shares granted	276,869		21.78
	Shares vested	(208,949)		23.11
	Shares forfeited	(417)		24.75
Non-vested shares at December 31, 2011		732,412	$	21.91
	Shares granted	281,429		26.78
	Shares vested	(183,019)		25.98
	Shares forfeited	(2,136)		26.26
Non-vested shares at December 31, 2012		828,686	$	22.50
	Shares granted	291,863		31.66
	Shares vested	(360,337)		21.55
	Shares forfeited	(16,343)		23.11
Non-vested shares at December 31, 2013		743,869	$	26.54

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at January 1, 2011		2,901,989	$	22.49	4.5
	Options exercised with total intrinsic value of $2,482,000	(374,350)		18.36
	Options terminated	(17,585)		25.42
Outstanding at December 31, 2011		2,510,054	$	23.09	3.4
	Options exercised with total intrinsic value of $6,287,000	(841,599)		21.64
	Options terminated	(5,625)		21.85
Outstanding at December 31, 2012		1,662,830	$	23.82	2.9
	Options exercised with total intrinsic value of $33,349,000	(1,392,366)		23.95
Outstanding at December 31, 2013 with aggregate intrinsic value of $6,156,000		270,464	$	23.16	2.5
Vested or expected to vest at December 31, 2013 with total intrinsic value of $6,156,000		270,464	$	23.16	2.5
Exercisable at December 31, 2013 with total intrinsic value of $6,156,000		270,464	$	23.16	2.5

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

						Per
			Earnings		Shares	Share
			(Numerator)		(Denominator)	Amount
For the year ended December 31, 2013:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	72,653	31,338	$	2.32
	Effect of dilutive securities options and non-vested shares			-	616
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	72,653	31,954	$	2.27
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	72,703	31,338	$	2.32
	Effect of dilutive securities options and non-vested shares			-	616
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	72,703	31,954	$	2.28
For the year ended December 31, 2012:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	62,235	30,773	$	2.02
	Effect of dilutive securities options and non-vested shares			-	835
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	62,235	31,608	$	1.97
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	62,563	30,773	$	2.03
	Effect of dilutive securities options and non-vested shares			-	835
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	62,563	31,608	$	1.98
For the year ended December 31, 2011:
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (basic)	$	50,025	30,452	$	1.64
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings from continuing operations attributable to
		AmSurg Corp. per common share (diluted)	$	50,025	31,211	$	1.60
	Net earnings attributable to AmSurg Corp. per common share (basic)		$	49,997	30,452	$	1.64
	Effect of dilutive securities options and non-vested shares			-	759
	Net earnings attributable to AmSurg Corp. per common share (diluted)		$	49,997	31,211	$	1.60